COMPUMEDICS EXECUTIVE CHAIRMAN, CEO DR. DAVID BURTON, INTERVIEWED ON SKY NEWS BUSINESS’ SUMMER MONEY SHOW
Sky News Business’ Summer Money Show interview held on the 29th Dec 2010 with Compumedics Executive Chairman, CEO Dr. David Burton. The interview clarified the substantial and imminent Compumedics USA and Europe direct sales force expansion opportunity, coupled with dynamic China market growth strategies, following the awarding of a series of prestigious 2010 Compumedics contracts.
MELBOURNE, Victoria., 31 Dec., 2010 — Compumedics Limited (ASX :CMP) is pleased to provide the link for the recent Sky News Business’ Summer Money Show interview held on the 29th Dec 2010 with Compumedics Executive Chairman, CEO Dr. David Burton. The interview clarified the substantial and imminent Compumedics USA and Europe direct sales force expansion opportunity, coupled with dynamic China market growth strategies, following the awarding of a series of prestigious 2010 Compumedics contracts.
To see the interview, simple click on the link below:
Compumedics Limited, was founded in 1987 by current Chairman/CEO Dr. David Burton and today is a global leader in the design and manufacture of diagnostic technologies for sleep disorders, neurophysiology and cardiology.
In 1987 Compumedics established Asia Pacific’s first fully computerized sleep laboratory. Compumedics holds 80% share of the Australian sleep-diagnostic market, and has a major and rapidly growing presence in the US, European and Asian marketplaces for its sleep, neurological, and Doppler blood-flow diagnostic monitoring devices.
In 1995 the company was selected to supply equipment to the US Sleep Heart Health Study, the world’s largest sleep study of its kind, with over 8,000 participants scheduled by 2008. With headquarters in Melbourne, Australia and offices in the United States, and Europe its products are distributed in over 50 countries.
In 1998 Compumedics was awarded the overall Australian Exporter of the Year.
In 2000 Compumedics was listed on the Australian Stock Exchange.
In 2002, Compumedics acquired US-based Neuroscan – the world’s leading supplier of instruments for brain research. In the US – the world’s largest medical device market – Neuroscan holds around 90% of the market for brain-research products.
In 2003 Compumedics was awarded the Frost & Sullivan Award for Market Expansion Strategy.
In 2004, Compumedics acquired Germany-basedDWL Elektronishe GmbH, enabling Compumedics to expand its global operations into the neurovascular and cardio-vascular diagnostic fields.
In 2006, Compumedics was awarded the Frost and Sullivan Technology Leadership award for its innovative Somté® recorder product.
In 2007, Compumedics and its Chairman were inducted into the Victorian Manufacturing Hall of Fame.
In 2008 the DWL division received a top 100 German Innovation award. With 20,000 systems installed globally across the finest hospital, universities and clinics Compumedics sales have grown more than 4-fold from $9 million (1999) to $39 million (2008).
In 2009 Compumedics was awarded a design award for its GRAEL® PSG/EEG premium laboratory-based product.
In 2010 Compumedics was recognized by the Australian Innovation Government and Industry body as one of Australia’s Top 100 Health Innovators through its’ world leading devices for sleep diagnostics.
For further background please visit: www.compumedics.com
For further information please contact:
Dr. David Burton
Mr. Rod North
T: 03 9510 8309
M: 0408 670 706
Investors: CMP.ASX (ASX.COM)